Risk Stratification and Treatment of Obesity for Primary and Secondary Prevention of Cardiovascular Disease

被引:0
|
作者
John W. Ostrominski
Tiffany M. Powell-Wiley
机构
[1] Brigham and Women’s Hospital and Harvard Medical School,Division of Cardiovascular Medicine
[2] Brigham and Women’s Hospital and Harvard Medical School,Division of Endocrinology, Diabetes and Hypertension
[3] National Heart,Social Determinants of Obesity and Cardiovascular Risk Laboratory, Cardiovascular Branch, Division of Intramural Research
[4] Lung and Blood Institute,Intramural Research Program
[5] National Institutes of Health,undefined
[6] National Institute on Minority Health and Health Disparities,undefined
[7] National Institutes of Health,undefined
来源
关键词
Obesity; Cardiometabolic disease; Prevention; Weight management; Social determinants of health; Pharmacotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:11 / 23
页数:12
相关论文
共 50 条
  • [1] Risk Stratification and Treatment of Obesity for Primary and Secondary Prevention of Cardiovascular Disease
    Ostrominski, John W.
    Powell-Wiley, Tiffany M.
    CURRENT ATHEROSCLEROSIS REPORTS, 2024, 26 (01) : 11 - 23
  • [2] Risk stratification in secondary cardiovascular prevention
    Lazzeroni, Davide
    Coruzzi, Paolo
    MINERVA CARDIOANGIOLOGICA, 2018, 66 (04): : 471 - 476
  • [3] OVERWEIGHT OR OBESITY FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE IN THE PRIMARY CARE SETTING AND CARDIOVASCULAR RISK
    Rodriguez, J.
    Villaverde, C.
    Perez, J.
    Panisello, J.
    Bleda, D.
    Trave, P.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [4] Aspirin for primary cardiovascular prevention: is there a need for risk stratification?
    Aimo, Alberto
    De Caterina, Raffaele
    EUROPEAN HEART JOURNAL, 2019, 40 (34) : 2922 - 2923
  • [5] Cardiovascular Disease in Women Primary and Secondary Cardiovascular Disease Prevention
    Sanghavi, Monika
    Gulati, Martha
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2016, 43 (02) : 265 - +
  • [6] Obesity and cardiovascular disease: From pathophysiology to risk stratification
    Marinou, Kyriakoula
    Tousoulis, Dimitris
    Antonopoulos, Alexios S.
    Stefanadi, Elli
    Stefanadis, Christodoulos
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 138 (01) : 3 - 8
  • [7] Secondary prevention of cardiovascular disease: Time to rethink stratification of disease severity?
    Akyea, Ralph K.
    Kai, Joe
    Qureshi, Nadeem
    Hamid, Hasidah Abdul
    Weng, Stephen F.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (16) : 1778 - 1780
  • [8] Effect of carotid atherosclerosis screening on risk stratification during primary cardiovascular disease prevention
    Bard, RL
    Kalsi, H
    Rubenfire, M
    Wakefield, T
    Fex, B
    Rajagopalan, S
    Brook, RD
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (08): : 1030 - 1032
  • [9] Aspirin for primary prevention of cardiovascular disease: Advice for a decisional strategy based on risk stratification
    Aimo, Alberto
    De Caterina, Raffaele
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2020, 23 (02): : 70 - 78
  • [10] Inflammatory markers for risk stratification in primary prevention of cardiovascular disease: Time for a 'multimarker' approach?
    Ikonomidis, I
    Lekakis, J
    Kremastinos, DT
    THROMBOSIS AND HAEMOSTASIS, 2006, 95 (03) : 397 - 398